Interleukin-1 receptor antagonist protects against lipopolysaccharide induced diaphragm weakness in preterm lambs.

Chorioamnionitis (inflammation of the fetal membranes) is strongly associated with preterm birth and in utero exposure to inflammation significantly impairs contractile function in the preterm lamb diaphragm. The fetal inflammatory response to intra-amniotic (IA) lipopolysaccharide (LPS) is orchestr...

Full description

Bibliographic Details
Main Authors: Kanakeswary Karisnan, Anthony J Bakker, Yong Song, Peter B Noble, J Jane Pillow, Gavin J Pinniger
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4393095?pdf=render
id doaj-50f57b2d409444f78a2d1e8102eaccf1
record_format Article
spelling doaj-50f57b2d409444f78a2d1e8102eaccf12020-11-25T01:19:51ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01104e012439010.1371/journal.pone.0124390Interleukin-1 receptor antagonist protects against lipopolysaccharide induced diaphragm weakness in preterm lambs.Kanakeswary KarisnanAnthony J BakkerYong SongPeter B NobleJ Jane PillowGavin J PinnigerChorioamnionitis (inflammation of the fetal membranes) is strongly associated with preterm birth and in utero exposure to inflammation significantly impairs contractile function in the preterm lamb diaphragm. The fetal inflammatory response to intra-amniotic (IA) lipopolysaccharide (LPS) is orchestrated via interleukin 1 (IL-1). We aimed to determine if LPS induced contractile dysfunction in the preterm diaphragm is mediated via the IL-1 pathway. Pregnant ewes received IA injections of recombinant human IL-1 receptor antagonist (rhIL-1ra) (Anakinra; 100 mg) or saline (Sal) 3 h prior to second IA injections of LPS (4 mg) or Sal at 119d gestational age (GA). Preterm lambs were killed after delivery at 121d GA (term = 150 d). Muscle fibres dissected from the right hemi-diaphragm were mounted in an in vitro muscle test system for assessment of contractile function. The left hemi-diaphragm was snap frozen for molecular and biochemical analyses. Maximum specific force in lambs exposed to IA LPS (Sal/LPS group) was 25% lower than in control lambs (Sal/Sal group; p=0.025). LPS-induced diaphragm weakness was associated with higher plasma IL-6 protein, diaphragm IL-1β mRNA and oxidised glutathione levels. Pre-treatment with rhIL-1ra (rhIL-1ra/LPS) ameliorated the LPS-induced diaphragm weakness and blocked systemic and local inflammatory responses, but did not prevent the rise in oxidised glutathione. These findings indicate that LPS induced diaphragm dysfunction is mediated via IL-1 and occurs independently of oxidative stress. Therefore, the IL-1 pathway represents a potential therapeutic target in the management of impaired diaphragm function in preterm infants.http://europepmc.org/articles/PMC4393095?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Kanakeswary Karisnan
Anthony J Bakker
Yong Song
Peter B Noble
J Jane Pillow
Gavin J Pinniger
spellingShingle Kanakeswary Karisnan
Anthony J Bakker
Yong Song
Peter B Noble
J Jane Pillow
Gavin J Pinniger
Interleukin-1 receptor antagonist protects against lipopolysaccharide induced diaphragm weakness in preterm lambs.
PLoS ONE
author_facet Kanakeswary Karisnan
Anthony J Bakker
Yong Song
Peter B Noble
J Jane Pillow
Gavin J Pinniger
author_sort Kanakeswary Karisnan
title Interleukin-1 receptor antagonist protects against lipopolysaccharide induced diaphragm weakness in preterm lambs.
title_short Interleukin-1 receptor antagonist protects against lipopolysaccharide induced diaphragm weakness in preterm lambs.
title_full Interleukin-1 receptor antagonist protects against lipopolysaccharide induced diaphragm weakness in preterm lambs.
title_fullStr Interleukin-1 receptor antagonist protects against lipopolysaccharide induced diaphragm weakness in preterm lambs.
title_full_unstemmed Interleukin-1 receptor antagonist protects against lipopolysaccharide induced diaphragm weakness in preterm lambs.
title_sort interleukin-1 receptor antagonist protects against lipopolysaccharide induced diaphragm weakness in preterm lambs.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description Chorioamnionitis (inflammation of the fetal membranes) is strongly associated with preterm birth and in utero exposure to inflammation significantly impairs contractile function in the preterm lamb diaphragm. The fetal inflammatory response to intra-amniotic (IA) lipopolysaccharide (LPS) is orchestrated via interleukin 1 (IL-1). We aimed to determine if LPS induced contractile dysfunction in the preterm diaphragm is mediated via the IL-1 pathway. Pregnant ewes received IA injections of recombinant human IL-1 receptor antagonist (rhIL-1ra) (Anakinra; 100 mg) or saline (Sal) 3 h prior to second IA injections of LPS (4 mg) or Sal at 119d gestational age (GA). Preterm lambs were killed after delivery at 121d GA (term = 150 d). Muscle fibres dissected from the right hemi-diaphragm were mounted in an in vitro muscle test system for assessment of contractile function. The left hemi-diaphragm was snap frozen for molecular and biochemical analyses. Maximum specific force in lambs exposed to IA LPS (Sal/LPS group) was 25% lower than in control lambs (Sal/Sal group; p=0.025). LPS-induced diaphragm weakness was associated with higher plasma IL-6 protein, diaphragm IL-1β mRNA and oxidised glutathione levels. Pre-treatment with rhIL-1ra (rhIL-1ra/LPS) ameliorated the LPS-induced diaphragm weakness and blocked systemic and local inflammatory responses, but did not prevent the rise in oxidised glutathione. These findings indicate that LPS induced diaphragm dysfunction is mediated via IL-1 and occurs independently of oxidative stress. Therefore, the IL-1 pathway represents a potential therapeutic target in the management of impaired diaphragm function in preterm infants.
url http://europepmc.org/articles/PMC4393095?pdf=render
work_keys_str_mv AT kanakeswarykarisnan interleukin1receptorantagonistprotectsagainstlipopolysaccharideinduceddiaphragmweaknessinpretermlambs
AT anthonyjbakker interleukin1receptorantagonistprotectsagainstlipopolysaccharideinduceddiaphragmweaknessinpretermlambs
AT yongsong interleukin1receptorantagonistprotectsagainstlipopolysaccharideinduceddiaphragmweaknessinpretermlambs
AT peterbnoble interleukin1receptorantagonistprotectsagainstlipopolysaccharideinduceddiaphragmweaknessinpretermlambs
AT jjanepillow interleukin1receptorantagonistprotectsagainstlipopolysaccharideinduceddiaphragmweaknessinpretermlambs
AT gavinjpinniger interleukin1receptorantagonistprotectsagainstlipopolysaccharideinduceddiaphragmweaknessinpretermlambs
_version_ 1725136925179772928